SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEjf Investments Regulatory News (EJFI)

Share Price Information for Ejf Investments (EJFI)

Share Price is delayed by 15 minutes
Get Live Data
130.00    -1.00 (-0.76%)
Bid:
126.00
Ask:
134.00
Spread: 8.00 (6.349%)
Market Cap: £75.51m
EJFI Live PriceLast checked at - London Stock Exchange

Intraday Ejf Investments Share Chart

PDMR Dealing

19 Feb 2021 09:56

RNS Number : 7300P
EJF Investments Ltd
19 February 2021
Β 

FOR IMMEDIATE RELEASE

Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE REPUBLIC OF IRELAND), AUSTRALIA, CANADA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.

Β 

19 February 2021

EJF INVESTMENTS LTD

PDMR Dealings

EJF Investments Ltd ("EJFI" or the "Company") announces in accordance with its Dealing Code that Joanna Dentskevich, Chair of the Board of Directors of the Company and a "person discharging managerial responsibilities" (a "PDMR") for the purposes of Regulation (EU) No 596/2014 on Market Abuse as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), conditionally agreed to purchase 28,348 ordinary shares of no par value in the Company ("Ordinary Shares") on 17 December 2020 at a price of 115 pence per share in a private transaction.

It should be noted that whilst the Sale and Purchase Agreement in relation to the purchase of the Ordinary Shares was signed on 17 December 2020, the transaction is currently subject to approval in accordance with the Company's AML process for off market transfers and the transfer of shares has therefore not yet been effected by the Company's registrar.

Following the settlement of this transaction, Joanna Dentskevich will be interested in 77,896 Ordinary Shares, representing approximately 0.13% of the issued Ordinary Shares, and 30,000 zero dividend preference shares with a redemption date in 2025 ("2025 ZDP Shares"), representing approximately 0.50% of the issued 2025 ZDP Shares.

Shares in the capital of the Company held in treasury have not been taken into account in the calculation of the above percentages.

The notification below, made in accordance with the requirements of MAR, provides further detail in relation to the above transaction:

1

Details of the person discharging managerial responsibilities / person closely associated

Β 

(a)

Name

Β 

Joanna Dentskevich

2

Reason for the notification

Β 

(a)

Position/status

Β 

Chair of the Board of Directors of the Company

(b)

Initial notification/Amendment

Β 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

Β 

EJF Investments Ltd

(b)

LEI

Β 

549300XZYEQCLA1ZAT25

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of financial instrument, type of instrument

Β 

Identification code

Ordinary shares of no par value

Β 

Β 

JE00BF0D1M25

Β 

(b)

Nature of the transactions

Β 

Purchase of ordinary shares

(c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

Β£1.15

Β 

28,348

Β 

(d)

Aggregate information

Β 

Β· Aggregated volume

Β 

Β· Price

Β 

Β 

Β 

28,348

Β 

Β£32,600.20

(e)

Date of transactions

Β 

17 December 2020

Please note that this is the date on which the Sale and Purchase Agreement in relation to the purchase of the Ordinary Shares was signed, however the transaction is currently subject to approval in accordance with the Company's AML process for off market transfers and the transfer of shares has therefore not yet been effected by the Company's registrar.

(f)

Place of transactions

Β 

Off-market

Β 

ENQUIRIES

For the Investment Manager

EJF Investments Manager LLC

Peter Stage / Hammad Khan / Matt Gill

pstage@ejfcap.com / hkhan@ejfcap.com / mgill@ejfcap.com

+44 203 752 6775 / +44 203 752 6771 / +44 203 752 6774

For the Company Secretary and Administrator

BNP Paribas Securities Services S.C.A. Jersey Branch

jersey.bp2s.ejf.cosec@bnpparibas.com

+44 1534 709 181/ +44 1534 813 996

Β 

For the Broker

Numis Securities Limited

David Luck

d.luck@numis.com

+44 20 7260 1301

About EJF Investments Ltd

EJFI is a registered closed-ended limited liability company incorporated in Jersey under the Companies (Jersey) Law 1991, as amended, on 20 October 2016 with registered number 122353. The Company is regulated by the Jersey Financial Services Commission (the "JFSC"). The JFSC is protected by both the Collective Investment Funds (Jersey) Law 1988 and the Financial Services (Jersey) Law 1998, as amended, against liability arising from the discharge of its functions under such laws.

The JFSC has not reviewed or approved this announcement.

LEI: 549300XZYEQCLA1ZAT25

Investor information & warnings

The latest available information on the Company can be accessed via its website at www.ejfi.com.

This communication has been issued by, and is the sole responsibility of, the Company and is for information purposes only. It is not, and is not intended to be an invitation, inducement, offer or solicitation to deal in the shares of the Company. The price and value of shares in the Company and the income from them may go down as well as up and investors may not get back the full amount invested on disposal of shares in the Company. An investment in the Company should be considered only as part of a balanced portfolio of which it should not form a disproportionate part. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUKVKRASUUARR
Date   Source Headline
28th Mar 20247:00 amRNSAnnual Financial Report to 31 December 2023
21st Mar 20247:00 amRNSNet Asset Value and Portfolio Update
15th Mar 202410:40 amRNSResults Presentation for the YE 31 December 2023
21st Feb 20247:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
31st Jan 20243:00 pmRNSQUARTERLY REPORT
29th Jan 20244:57 pmRNSDividend Declaration - Replacement
29th Jan 20247:00 amRNSDividend Declaration
22nd Jan 20247:00 amRNSNet Asset Value and Portfolio Update
22nd Dec 20237:00 amRNSCorporate Update
20th Dec 20237:00 amRNSNet Asset Value and Portfolio Update
21st Nov 20237:00 amRNSNet Asset Value and Portfolio Update
2nd Nov 202310:43 amRNSQUARTERLY REPORT
25th Oct 20237:00 amRNSDividend Declaration
20th Oct 20237:00 amRNSNet Asset Value(s)
21st Sep 20237:00 amRNSNet Asset Value and Portfolio Update
8th Sep 20237:00 amRNSHalf-year Report
25th Aug 20234:32 pmRNSUpdate to composition of the Board of Directors
23rd Aug 20232:42 pmRNSNotice of Interim Results and Results Presentation
21st Aug 20237:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
1st Aug 20237:00 amRNSQUARTERLY REPORT
27th Jul 20235:34 pmRNSDividend Declaration
27th Jul 20237:00 amRNSPortfolio Update
20th Jul 20237:00 amRNSNet Asset Value and Portfolio Update
21st Jun 20237:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
21st Jun 20237:00 amRNSCORPORATE UPDATE
13th Jun 20234:07 pmRNSResult of AGM
25th May 20239:14 amRNSQuarterly Report
24th May 20237:00 amRNSNet Asset Value and Portfolio Update
18th May 20235:22 pmRNSNotice of AGM
26th Apr 20233:13 pmRNSDividend Declaration
25th Apr 20235:12 pmRNSDividend Declaration
25th Apr 20237:00 amRNSNet Asset Value(s)
5th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
31st Mar 20237:00 amRNSAnnual Financial Report to 31 December 2022
29th Mar 20237:00 amRNSPortfolio Update
21st Mar 20237:00 amRNSNet Asset Value(s)
15th Mar 20237:00 amRNSPortfolio Update
27th Feb 20237:00 amRNSResults of Placing
21st Feb 20237:00 amRNSNet Asset Value(s)
20th Feb 20237:00 amRNSIssue of 2025 ZDP Shares under Placing Programme
26th Jan 20235:07 pmRNSDividend Declaration
23rd Jan 20237:00 amRNSNet Asset Value(s)
11th Jan 20232:10 pmRNSCorporate Update
21st Dec 20227:00 amRNSNet Asset Value(s)
21st Nov 20227:00 amRNSNet Asset Value(s)
16th Nov 20224:21 pmRNSDirector/PDMR Shareholding
1st Nov 20227:00 amRNSRedemption of 2022 ZDP Shares
27th Oct 20224:57 pmRNSDividend Declaration
21st Oct 20227:00 amRNSNet Asset Value and Corporate Update
22nd Sep 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.